- Buprenorphine-naloxone is a medication for opioid use disorder, and for many people staying on it long-term is the safer, evidence-supported choice rather than a sign of unfinished recovery.
- Stopping too soon is linked to a high risk of relapse and, because tolerance falls, a raised risk of overdose; the decision to taper belongs with the prescriber who manages your care.
- If a taper is right for you, it is generally slow, gradual, and individualized, with the option to pause or resume the medication if things become unstable.
- Stopping suddenly can bring on opioid withdrawal, so any change should be planned with your clinician rather than made on your own.
- This is general education only. It is not a schedule to follow alone, and it is not a substitute for personalized medical care.
Suboxone is a brand name for a combination of buprenorphine and naloxone, a medication used to treat opioid use disorder. Buprenorphine is a partial opioid agonist that eases cravings and prevents withdrawal, while the naloxone component is included to discourage misuse. If you take it as prescribed, this medication is doing an important job, and many people stay on it for a long time. Because of that, “tapering off” is a bigger decision than it may sound, and it is not something to start on your own. This article explains, in general terms, why the timing matters, why any taper must be prescriber-supervised, and what the process tends to involve. It is education only, not a plan to follow alone.
First, a word about staying on it
It is worth being clear up front: for many people, remaining on buprenorphine-naloxone long-term is the safer choice, not a failure or a step that needs to be “finished.” Medication for opioid use disorder is one of the most effective treatments in medicine, and peer-reviewed research in the National Library of Medicine’s archives links longer retention in treatment with better outcomes, while short tapers are associated with a high likelihood of returning to use. Stopping is not a required goal of recovery. If you are feeling pressure to come off, whether from yourself, family, cost, or stigma, that is exactly the thing to talk through with your prescriber rather than act on alone. The right length of treatment is individual, and for some people it is indefinite.
Why people consider tapering
People think about reducing buprenorphine-naloxone for many reasons: they feel stable and want to try life without a daily medication, they are managing side effects, they face access or cost barriers, or they are planning around pregnancy or another medical event. All of these are worth discussing, but none of them should trigger an unplanned stop. A prescriber can help you weigh whether now is a stable moment to attempt a taper, or whether staying the course is the wiser call.
Why a taper must be prescriber-supervised
There is no single taper that fits everyone. The right approach depends on your dose, how long you have been in treatment, your history, your mental health, your support system, and how stable your life is right now. MedlinePlus, the National Library of Medicine’s consumer drug resource, is explicit that you should not stop taking buprenorphine and naloxone without talking to your doctor, and that your doctor will tell you when and how to stop. A clinician can slow the pace, pause, or resume the full dose if cravings or instability return, which is a safety net you simply do not have on your own. This is also why you should never start, stop, or change this medication by yourself. If cost or access is the pressure, tell your prescriber; there are often ways to keep treatment going.
The danger of stopping abruptly or too soon
Two distinct risks matter here. First, stopping buprenorphine-naloxone too quickly can bring on opioid withdrawal, with symptoms MedlinePlus describes such as restlessness, watery eyes, runny nose, sweating, chills, muscle pain, nausea, vomiting, and diarrhea. Second, and more serious, is the risk that comes after stopping: research in the National Library of Medicine’s PMC collection has documented that discontinuing long-term buprenorphine treatment is associated with a substantial risk of return to opioid use, and because tolerance drops once the medication is out of your system, a return to use carries a heightened risk of overdose. That combination, high relapse rates plus lost tolerance, is the core reason clinicians are cautious about ending treatment and why the decision is never made lightly or alone.
General principles if a taper is right for you
When a prescriber and patient do decide to taper, the underlying principles are consistent: it is slow, gradual, and individualized, and it is done from a position of stability rather than during a crisis. Rather than large jumps, the dose comes down in small steps, with time between reductions to see how you feel before going further. A good plan is flexible: if cravings, low mood, or instability appear, the plan slows down, pauses, or steps back up rather than pushing ahead. Many clinicians also keep the door open, meaning that resuming medication is treated as a sensible clinical response, not a setback. Ongoing counseling, peer support, and monitoring are usually part of the picture throughout. What a taper is not is a fixed mg-by-week countdown you can copy from an article; the specifics belong to you and your clinician.
What tapering can feel like, and how long
Because buprenorphine is long-acting, symptoms during a well-managed taper are often milder and more spread out than the withdrawal people associate with short-acting opioids, but experiences vary a great deal. Some people notice low-level withdrawal features, disrupted sleep, aches, low mood, or a rise in cravings as the dose lowers. The timeline is genuinely individual and can stretch over months, which is normal and often preferable. There is no prize for rushing, and a slower taper is generally gentler. Cravings that return are information, not failure, and they are a signal to talk with your prescriber about adjusting the plan.
Coping and support during and after a taper
Support makes a real difference. Staying connected to counseling or a recovery program, keeping regular sleep and meals, gentle activity, and leaning on trusted people all help. Because the period after stopping carries overdose risk, some clinicians discuss keeping naloxone (the overdose-reversal medication) on hand and making sure loved ones know how to use it. If you want confidential, free help finding or staying in treatment, the SAMHSA National Helpline at 1-800-662-4357 is available 24 hours a day, every day. If you ever feel unsafe or have thoughts of harming yourself, call or text 988, the Suicide and Crisis Lifeline, and call 911 in an emergency.
Frequently asked questions
Do I have to come off Suboxone eventually?
No. For many people, long-term maintenance is the safer, evidence-supported choice, and staying on it is not a sign of unfinished recovery. Whether and when to taper is a decision to make with your prescriber.
Is stopping Suboxone dangerous?
Stopping suddenly can cause withdrawal, and stopping too soon raises the risk of returning to opioid use, which carries overdose risk because tolerance falls. That is why any change should be prescriber-led.
How long does tapering take?
It varies widely and is often best done slowly over months. A clinician sets the pace based on your stability and how you respond, and there is no benefit to rushing.
What if cravings come back during a taper?
Tell your prescriber promptly. Returning cravings are a signal to slow down, pause, or resume the medication, all of which are normal clinical responses rather than failures.
Can I restart if a taper does not go well?
Yes. Resuming medication is a sensible and common step, and keeping that option open is part of a safe plan. Do not try to manage a restart on your own.
Should I keep naloxone on hand?
Many clinicians recommend it, especially during and after a taper when overdose risk rises. Ask your prescriber about carrying naloxone and teaching those around you to use it.
This article is general education, not medical advice, and must not be used to start, stop, adjust, or taper any medication on your own. Suddenly stopping some medicines can be dangerous. Always work with the prescriber who manages your care. In an emergency call 911; for mental-health crisis call or text 988.
Sources
- MedlinePlus, National Library of Medicine — Buprenorphine and Naloxone (sublingual)
- StatPearls, NCBI Bookshelf, National Library of Medicine — Buprenorphine
- CDC — 2022 Clinical Practice Guideline for Prescribing Opioids for Pain
- SAMHSA — Medications for Opioid Use Disorder and National Helpline (1-800-662-4357)
- Peer-reviewed research on buprenorphine maintenance, discontinuation, and relapse risk (PMC, National Library of Medicine)